Please wait...

Learn

Finding accredited CPD

Multiple Sclerosis Research Review Issue 92

Description

Multiple Sclerosis Research Review Issue 92 with commentary by Clinical Professor Todd Hardy.

This review is a unique Australian publication providing topical, relevant and accessible information for health professionals with an interest in Multiple Sclerosis. In essence, the review is a summary of what we consider to be some of the most significant new studies in this area.

Details

In this edition we feature:

- ANO2-specific T-cells & EBNA-1 in MS

- AI redefines MS as a disease continuum

- Diagnostic role of PRLs at first clinical presentation

- Secondary autoimmunity after immune reconstitution therapies in MS

- Lifestyle factors in benign/non-benign MS

- Frequency of critical demyelinating lesions in progressive MS

- Finite-course ocrelizumab vs. standard-interval dosing in relapsing MS

- DMTs in late-onset MS

- Case report: tenofovir alafenamide fumarate in PML

- Myelin injury in pre-symptomatic MS.

To access this publication please click ‘Enrol Now’ and you’ll be directed to the publication. Then sign up to Research Review at no cost. You can then login with your email and password. If you require any assistance please email Research Review – trish@researchreview.com.au

This activity is accepted by CPD Home as a Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide.

Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.

Provided by

CPD Activity Details

Topic

Nervous System Diseases

CAPE Aspects

Effective Year

Educational Activities (EA) - 0.30

Reviewing Performance (RP) - 0.0

Measuring Outcomes (MO) - 0.0

You have to log in to see the content of this module.